These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7431212)

  • 1. [Aspect on corneal permeability of bupranolol (author's transl)].
    Iwata S; Ohtani Y; Osada E; Ogino H
    Yakugaku Zasshi; 1980 Apr; 100(4):402-6. PubMed ID: 7431212
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies of bupranolol therapy for glaucoma. 1. Ocular penetration and hypotensive effect (author's transl)].
    Komuro S; Nanba H; Takase M
    Nippon Ganka Gakkai Zasshi; 1979 Jun; 83(6):537-41. PubMed ID: 484390
    [No Abstract]   [Full Text] [Related]  

  • 3. A radioautographic study on the incorporation of 14C-bupranolol (beta-blocking agent) into the rabbit eye.
    Tsukahara S; Yoshida K; Nagata T
    Histochemistry; 1980; 68(3):237-44. PubMed ID: 7462003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetic studies on the penetration and distribution of bupranolol in the rabbit eye].
    Schmitz J; Dahnke HG; Zemitis A; Koglin K; Mosebach KO; Dardenne MU
    Fortschr Ophthalmol; 1982; 79(4):374-8. PubMed ID: 7185717
    [No Abstract]   [Full Text] [Related]  

  • 5. [Scanning electron microscopic studies on the cornea of rabbit after chronic topical administration of 1% bupranolol (author's transl)].
    Araki M; Ogata T
    Nippon Ganka Gakkai Zasshi; 1980 Sep; 84(9):1376-84. PubMed ID: 7223567
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of bupranolol hydrochloride (KL 255) on cyclic AMP level of aqueous humor, iris and ciliary body of albino rabbit (author's transl)].
    Tamura T; Osada E; Ueno K
    Nippon Ganka Gakkai Zasshi; 1978 Jul; 82(7):517-21. PubMed ID: 211836
    [No Abstract]   [Full Text] [Related]  

  • 7. [Electron microscopic observations of the ciliary epithelium of rabbit after chronic topical administration of 1% bupranolol (author's transl)].
    Araki M; Ogata T
    Nippon Ganka Gakkai Zasshi; 1980 Oct; 84(10):1731-7. PubMed ID: 7257991
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic fate of the beta-blocker 14C-bupranolol in humans, dogs, and rhesus monkeys.
    Waller AR; Chasseaud LF; Bonn R; Taylor T; Darragh A; Girkin R; Down WH; Doyle E
    Drug Metab Dispos; 1982; 10(1):51-4. PubMed ID: 6124383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term treatment of angle-closure glaucoma with bupranolol eye drops (author's transl)].
    Demmler N
    Klin Monbl Augenheilkd; 1980 Nov; 177(5):618-21. PubMed ID: 7253517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on corneal permeability of drugs. I. Effect of modification of drugs on corneal permeability (author's transl)].
    Kishida K; Ueno N; Otori T
    Nippon Ganka Gakkai Zasshi; 1973 Aug; 77(8):804-8. PubMed ID: 4798972
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term treatment of open-angle glaucoma with bupranolol eye drops (author's transl)].
    Demmler N
    Klin Monbl Augenheilkd; 1980 Oct; 177(4):523-6. PubMed ID: 7253504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of topical bupranolol on glaucoma eyes (author's transl)].
    Miki H; Moriyama R; Itagaki Y
    Nippon Ganka Gakkai Zasshi; 1981 Feb; 85(2):169-74. PubMed ID: 7258011
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bupranolol eye-drops (Ophtorenin) in long-term therapy of glaucoma (author's transl)].
    Stiegler G
    Klin Monbl Augenheilkd; 1979 Feb; 174(2):267-75. PubMed ID: 439706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of neuroleptic-induced tremor with the beta-blocker bupranolol (author's transl)].
    Floru L; Brosteanu ER; Lehmann E; Schottenfeld Y
    Arzneimittelforschung; 1979; 29(1):142-5. PubMed ID: 36103
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the inhibition of thrombocyte aggregation by bupranolol / Aggregometric and electron microscopic study in vitro (author's transl)].
    Zwillenberg LO; Bösiger G
    Arzneimittelforschung; 1980; 30(3):483-7. PubMed ID: 7387760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effects of oral bupranolol on intraocular pressure of primary open-angle glaucoma (author's transl)].
    Fujinaga Y; Yamanishi Y; Setogawa T
    Nippon Ganka Gakkai Zasshi; 1979 Sep; 83(9):1764-7. PubMed ID: 525603
    [No Abstract]   [Full Text] [Related]  

  • 17. [Longterm bupranolol therapy in glaucoma eyes: a one to two year follow up study (author's transl)].
    Miki H
    Nippon Ganka Gakkai Zasshi; 1982; 86(3):269-78. PubMed ID: 7102479
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies of bupranolol therapy for glaucoma. 2. Dose response and comparing to pilocarpine on intraocular pressure (author's transl)].
    Totsuka H; Matsuo T; Araie M; Takase M
    Nippon Ganka Gakkai Zasshi; 1979; 83(11):2166-75. PubMed ID: 546205
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on befunolol-metabolizing activities, especially on reducing activity (author's transl)].
    Tohno M; Yamamoto T; Kajikawa N; Ofuji T
    Yakugaku Zasshi; 1980 Apr; 100(4):443-51. PubMed ID: 7437132
    [No Abstract]   [Full Text] [Related]  

  • 20. [In vitro studies on species differences in befunolol-metabolizing activities (author's transl)].
    Tohno M; Kajikawa N; Yamamoto T; Ofuji T
    Yakugaku Zasshi; 1980 Sep; 100(9):933-40. PubMed ID: 7218154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.